Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Cash from Operations (2021 - 2025)

Cardio Diagnostics Holdings' Cash from Operations history spans 5 years, with the latest figure at 1393418.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 20.4% year-over-year to 1393418.0; the TTM value through Sep 2025 reached 5757279.0, down 8.91%, while the annual FY2024 figure was 4993104.0, 11.97% up from the prior year.
  • Cash from Operations for Q3 2025 was 1393418.0 at Cardio Diagnostics Holdings, up from 1571465.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 174.0 in Q3 2021 and bottomed at 3120265.0 in Q4 2022.
  • The 5-year median for Cash from Operations is 1292832.0 (2023), against an average of 1201314.65.
  • The largest annual shift saw Cash from Operations crashed 798659.2% in 2022 before it skyrocketed 45.98% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 300944.0 in 2021, then crashed by 936.83% to 3120265.0 in 2022, then skyrocketed by 45.98% to 1685677.0 in 2023, then grew by 17.4% to 1392295.0 in 2024, then dropped by 0.08% to 1393418.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Cash from Operations are 1393418.0 (Q3 2025), 1571465.0 (Q2 2025), and 1400101.0 (Q1 2025).